Standard Operating Procedures. Active Pharmacovigilance Surveillance: Drug Safety Monitoring for New Medicines and Novel Regimens of the National TB Program in the Philippines
(2015; 21 pages)

Management Sciences for Health (MSH). Standard Operating Procedures. Active Pharmacovigilance Surveillance: Drug Safety Monitoring for New Medicines and Novel Regimens of the National TB Program in the Philippines. Manila, Philippines: MSH; 2015.

Abstract

The purpose of this standard operating procedure is to outline a step-by-step approach for undertaking active drug safety monitoring for the 9-month MDR-TB treatment regimen and other novel medications and regimens for TB and MDR-TB.

The Philippines is committed to introducing evidence-based novel medicines and treatment strategies that are likely to benefit TB and MDR-TB patients. . The National TB Control Program will do this in a comprehensive way that reinforces the principles of World Health Organization (WHO) guidelines for the programmatic management of drug-resistant tuberculosis, ensuring that the introduction of the novel medicines and regimens in the Philippines maximizes the benefits and minimizes the risks to patients and communities.

 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018